Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of N-Acetyl Cysteine on Diabetic Retinopathy
NCT07634991Phase 4Recruiting
- Sponsor
- Ain Shams University
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetic retinopathy (DR) comparing Placebo with N-acetyl cysteine (2 arms). Primary endpoint: Changes in glutathione peroxidase levels at 3 months. Started Jan 2026; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT07634991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07634991.